Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees.
Year: 2015
Type: article
Abstract: P&T committees will play a key role in driving the adoption of biosimilars, which have unique characteristics compared with small-molecule generic drugs. Key elements of formulary review will include clinical parameters, product characteristics, and institutional considerations, which are among the issues covered in this article.
Source: Europe PMC (PubMed Central)
Author: C Lee Ventola
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1936638656
